Loading...
•
Sep 30, 2022
ResMed Q1 2023 Earnings Report
ResMed's first quarter of fiscal year 2023 demonstrated revenue growth and solid performance.
Key Takeaways
ResMed Inc. reported a 5% increase in revenue to $950.3 million, with a diluted earnings per share of $1.43 and non-GAAP diluted earnings per share of $1.51.
Revenue increased by 5% to $950.3 million; up 9% on a constant currency basis.
Gross margin expanded by 90 bps to 56.9%; non-GAAP gross margin expanded by 40 bps to 57.6%.
Income from operations increased 5%; non-GAAP operating profit up 4%.
Diluted earnings per share of $1.43; non-GAAP diluted earnings per share of $1.51.
ResMed
ResMed
ResMed Revenue by Geographic Location
Revenue by Geographic Location
U.S., Canada, and Latin America Revenue
CapyFin.comEurope, Asia, and other markets Revenue
CapyFin.com Forward Guidance
No forward guidance was provided in the press release.
Revenue & Expenses
Visualization of income flow from segment revenue to net income